Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by &Partners

&Partners raised its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 21,540 shares of the pharmacy operator’s stock after buying an additional 2,751 shares during the period. &Partners’ holdings in Walgreens Boots Alliance were worth $467,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Highlander Capital Management LLC purchased a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $26,000. Pineridge Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at approximately $26,000. Venturi Wealth Management LLC raised its position in shares of Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 981 shares during the period. Rocky Mountain Advisers LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at approximately $30,000. Finally, Quest Partners LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at approximately $30,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Inderpal S. Bhandari bought 3,000 shares of the stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares in the company, valued at approximately $54,150. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CFO Manmohan Mahajan purchased 6,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on WBA shares. UBS Group reduced their price target on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 3rd. Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Bank of America reduced their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. Morgan Stanley dropped their target price on shares of Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating for the company in a report on Friday, May 31st. Finally, SVB Leerink dropped their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a report on Monday, March 18th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average target price of $23.57.

Walgreens Boots Alliance Stock Up 0.6 %

Shares of NASDAQ:WBA traded up $0.10 during trading on Friday, hitting $15.97. The company’s stock had a trading volume of 18,512,322 shares, compared to its average volume of 11,448,399. The business has a 50 day moving average price of $16.84 and a two-hundred day moving average price of $20.47. The company has a market capitalization of $13.78 billion, a PE ratio of -2.28, a P/E/G ratio of 0.99 and a beta of 0.78. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. Walgreens Boots Alliance, Inc. has a fifty-two week low of $14.62 and a fifty-two week high of $32.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.16 earnings per share. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 3.21 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.26%. Walgreens Boots Alliance’s payout ratio is currently -14.29%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.